Morana Jovan-Embiricos

Insider Reports History

Entity
Individual
Location
C/O Radius Health, Inc., 201 Broadway, 6 Th Floor, Boston, MA
Signature
/s/ Brett Hagen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Morana Jovan-Embiricos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1.31M $16.3M $12.46 Jun 24, 2022 By F2 Vision SCS
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1.14M $14.2M $12.46 Jun 24, 2022 By Globeways Holdings Ltd.
Allovir, Inc. Director, 10%+ Owner Common Stock 16.7M $13.2M $0.79 Jun 6, 2024 Shares held by ElevateBio LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 622K $7.75M $12.46 Jun 24, 2022 By F2-TPO Investments, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 537K $6.7M $12.46 Jun 24, 2022 By F2 Bioscience I 2017 Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 325K $4.05M $12.46 Jun 24, 2022 By F2 MG Ltd.
Allovir, Inc. Director, 10%+ Owner Common Stock 4.19M $3.32M $0.79 Jun 6, 2024 F2 Capital I 2020 LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 215K $2.68M $12.46 Jun 24, 2022 By F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 208K $2.59M $12.46 Jun 24, 2022 Direct
Allovir, Inc. Director, 10%+ Owner Common Stock 2.06M $1.63M $0.79 Jun 6, 2024 F2 MG Ltd.
Allovir, Inc. Director, 10%+ Owner Common Stock 2.04M $1.62M $0.79 Jun 6, 2024 Shares held by F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 105K $1.31M $12.46 Jun 24, 2022 By F2 GC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 71.6K $892K $12.46 Jun 24, 2022 By F2 Bio TD, LLC
Allovir, Inc. Director, 10%+ Owner Common Stock 868K $687K $0.79 Jun 6, 2024 F2 Bioscience AV 2022 LLC
Allovir, Inc. Director, 10%+ Owner Common Stock 668K $529K $0.79 Jun 6, 2024 Shares held by F2 TPO Investments, LLC
Allovir, Inc. Director, 10%+ Owner Common Stock 100K $79.4K $0.79 Jun 6, 2024 Direct
Cullinan Oncology, Inc. 10%+ Owner Stock Option (Right to Buy) 0 Jun 24, 2022 Direct

Insider Reports Filed by Morana Jovan-Embiricos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALVR Allovir, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
ALVR Allovir, Inc. May 11, 2023 1 $0 4 May 12, 2023 Director, 10%+ Owner
ALVR Allovir, Inc. Jul 28, 2022 6 $37.6M 4 Aug 1, 2022 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Jun 24, 2022 5 $13.80 4 Jun 28, 2022 10%+ Owner
ALVR Allovir, Inc. May 17, 2022 1 $0 4 May 19, 2022 Director, 10%+ Owner
ALVR Allovir, Inc. Nov 10, 2021 2 -$19.8K 4 Nov 15, 2021 Director
ALVR Allovir, Inc. Nov 5, 2021 4 -$302K 4 Nov 9, 2021 Director
ALVR Allovir, Inc. Oct 27, 2021 2 -$54.5K 4 Oct 29, 2021 Director
ALVR Allovir, Inc. Oct 21, 2021 6 -$337K 4 Oct 25, 2021 Director
CGEM Cullinan Oncology, Inc. Sep 16, 2021 1 $0 4 Mar 25, 2022 Director
ALVR Allovir, Inc. May 25, 2021 1 $0 4 May 27, 2021 Director, 10%+ Owner